title: [Administration of intrapartum erythromycin for the interruption of the vertical transmission of Ureaplasma urealyticum and its possible relation to the development of bronchopulmonary dysplasia in neonates with less than 32 weeks gestation. Multicenter study].
authors.affiliation: Servicio de Neonatología, Hospital Universitario Materno-infantil Valle de Hebrón Ciudad Sanitaria Valle de Hebrón, Barcelona.
authors.forename: S
authors.initials: S
authors.lastname: Salcedo Abizanda
authors.forename: L
authors.initials: L
authors.lastname: Cabero Roura
authors.forename: A
authors.initials: A
authors.lastname: Andreu Domingo
authors.forename: J
authors.initials: J
authors.lastname: Lucaya Layret
authors.forename: J
authors.initials: J
authors.lastname: Perapoch López
authors.forename: M
authors.initials: M
authors.lastname: Casellas Caro
authors.forename: F
authors.initials: F
authors.lastname: Fernández Pérez
authors.forename: M
authors.initials: M
authors.lastname: Campins Martí
authors.forename: N
authors.initials: N
authors.lastname: Torán Fuentes
authors.forename: G
authors.initials: G
authors.lastname: Peguero Monforte
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001997:Bronchopulmonary Dysplasia / Q000209:etiology*; D004917:Erythromycin / Q000627:therapeutic use*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D018445:Infectious Disease Transmission, Vertical; D016869:Ureaplasma Infections / Q000150:complications / Q000517:prevention & control* / Q000635:transmission; D016990:Ureaplasma urealyticum
chemical_list: D000900:Anti-Bacterial Agents; D004917:Erythromycin